Jump to content

Canadian Plasma Resources

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 333-blue (talk | contribs) at 02:27, 6 March 2016 (Unmarking submission as under review (AFCH 0.9)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Canadian Plasma Resources
Formation2012
Key people
Dr. Barzin Bahardoust, CEO
Websitewww.giveplasma.ca

Canadian Plasma Resources (CPR) is a biopharmaceutical company based in Saskatoon , Saskatchewan, Canada. It was founded in 2012 and specializes in collection of source plasma for further manufacturing and contract-manufacturing of plasma-based bio-pharmaceuticals. CPR is one of the only four establishments in Canada that are licenced to collect plasma the others are Canadian Blood Services (CBS), Hema-Quebec and Cangene now owned by ProMetic Life Sciences Inc.

History

Canadian Plasma Resources (CPR) was founded in 2012 in Toronto, Ontario. Initially, CPR had planned to base its operation in the Greater Toronto and Hamilton Area. As a result, CPR, established two plasma collection centers in Toronto.[1]. Both of these centers obtained authorization from the Biologics and Genetic Therapies Directorate of Health Canada and were granted establishment licences in 2014. Like similar operations in the US and some European countries CPR provides compensation for the donor’s time [2]. This created much controversy centered around the paid donor model [3]. At the request of the government of Ontario [4] Health Canada organized a public consultation] [5] and concluded that donor compensation is not a safety concern; therefore, it will not prohibit donor compensation [6]. In spite of this, in 2014, the government of Ontario introduced legislation specifically to prohibit CPR from operating in Ontario [7][8]. Several stakeholders including the Canadian Blood Services (CBS) and many patient organizations argued that prohibiting pay-for-plasma would harm patients [9][10][11]; however this did not change the position of the Ontario government [12]. By that time CPR had already received strong support from several other Canadian provincial governments [13] citing Canada’s over reliance on other countries with paid donor models for procurement of plasma products. In 2015, CPR decided to relocate its operation to Saskatchewan [14]. The company’s first facility in Saskatchewan received Health Canada licence in early 2016 and was formally opened on February 18, 2016 by Minister Dustin Duncan, Saskatchewan’s minister of Health [15].

Operations

Canadian plasma resources’ plasma collection facility is located in Saskatoon, Saskatchewan. Plasma collection is done through automated apheresis. To ensure donor and product safety each centre is operated under the responsibility of a licensed physician and certain tasks are delegated by the physician to registered nurses. Plasma from these operations can only be used for further manufacturing into therapies such as immunoglobulin, human serum albumin and blood coagulation factors, which are among the World Health Organizations list of essential medicines. This collected plasma cannot be used for direct transfusion into patients. CPR is licensed by Health Canada for component preparation and testing. Health Canada is considered a leader in blood safety regulations as recognized by the World Health Organization[16]

Products

  • Source plasma for further manufacturing (licenced by Health Canada)
  • Intravenous Immunoglobulin (not licensed in Canada at the moment)

References


Category:Articles created via the Article Wizard